Professor of Psychology Charan Ranganath and his colleagues are developing biomarkers to identify individuals with preclinical Alzheimer’s disease.
They’ve focused their sights on an area of the brain called the lateral entorhinal cortex (LEC), which is ground zero for damage in preclinical Alzheimer's disease.
Ranganath and his team are figuring out how to assess this pathology in a noninvasive way.
